FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Bernard Gordon R 2. Date of Event Requiring Statement (Month/Day/Year) 08/10/2009 3. Issuer Name and Ticker or Trading Symbol CUMBERLAND PHARMACEUTICALS INC [CPIX] (Last) (First) (Middle) 2525 WEST END AVE., SUITE 950 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Senior Vice President 5. If Amendment, Date Original Filed(Month/Day/Year) 08/10/2009 (Street) NASHVILLE, TN 37203 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (1)	12/31/2008	07/31/2018	Common stock	563	$ 13	D	Â
Options (1)	12/31/2008	07/31/2018	Common stock	563	$ 13	D	Â
Options (1)	12/31/2008	07/31/2018	Common stock	562	$ 13	D	Â
Options (1)	12/31/2008	07/31/2018	Common stock	562	$ 13	D	Â
Options	12/31/2009	02/16/2019	Common stock	500 (2)	$ 13	D	Â
Options	12/31/2010	02/16/2019	Common stock	500 (2)	$ 13	D	Â
Options	12/31/2011	02/16/2019	Common stock	500 (2)	$ 13	D	Â
Options	12/31/2012	02/16/2019	Common stock	500 (2)	$ 13	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Bernard Gordon R 2525 WEST END AVE. SUITE 950 NASHVILLE, TN 37203	Â	Â	  Senior Vice President	Â

Signatures

Gordon Bernard: /s/ David L. Lowrance, as attorney-in-fact		01/06/2010
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The original Form 3 did not identify the award as vesting over a four-year period ending December 31, 2011. As such, the Date Exercisable per the original Form 3 was incorrect. In addition, the expiration date is July 31, 2018 rather than July 22, 2018 (as per the original Form 3).
(2)	The original Form 3 incorrectly identified the vesting schedule to be 563, 563, 562 and 562 as of December 31, 2009, 2010, 2011 and 2012, respectively.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.